According to research published in Neurology, women who use oestrogen-only hormone therapy exhibit a 39 percent lower risk of receiving a clinical dementia diagnosis and a 35 percent reduction in Alzheimer’s disease signs at autopsy, though investigators caution the observational data only shows an association rather than direct prevention. The study analyzed medical records from 21,462 female participants across two large American datasets, examining brain tissue samples from nearly 3,000 donors alongside clinical data to evaluate the relationship between menopause hormone treatments and neurodegenerative biomarkers.
Understanding the Link Between Oestrogen and Brain Health
Alzheimer’s disease disproportionately affects women, accounting for roughly two-thirds of all cases, according to data highlighted by Scientific American. While longevity, social factors, and genetics contribute to this disparity, cognitive neuroscientist Jennifer Bruno of Stanford University points to menopause as a critical inflection point. During menopause, ovaries stop producing mature eggs and estrogen production slows sharply. This drop may influence how brains age and alter vulnerability to cognitive decline, according to Bruno.
Estrogen plays vital roles in protecting brain cells, supporting mitochondrial energy production, maintaining neural connections, and promoting cerebral blood flow, as noted by HelpDementia. When levels fall, these protective mechanisms diminish. Initiating estrogen therapy close to the onset of menopause appears associated with a neutral or beneficial effect on Alzheimer’s risk, helping reduce amyloid-beta accumulation and tau tangles. However, starting treatment long after menopause may not provide these benefits.
Study Methodology and Autopsy Findings
The research team combined clinical records with biomarkers and post-mortem brain tissue evidence. Jacob Shaw, a study co-author and psychiatry resident at Massachusetts General Hospital/McLean Hospital, notes that researchers carefully adjusted for confounding variables including age, education, genetics, race, and hypertension. Among the nearly 3,000 patients who donated their brains to science, those taking oestrogen showed fewer neurobiological hallmarks of Alzheimer’s disease, such as beta-amyloid plaques and tau protein tangles.
Did you know? Dementia has been the leading cause of death for women in the UK for over a decade, yet researchers are still working to fully understand why females are disproportionately affected compared to males.
Limitations and Current Medical Guidelines
Experts emphasize that the findings do not establish causation. Hadi Hosseini, a neuroscientist at Stanford University and senior author of the study, explains that women taking hormone therapy might be healthier overall or have better access to healthcare. Furthermore, the average age of oestrogen use among participants was roughly 70, which differs substantially from standard contemporary hormone replacement therapy practices.
Dr Tom Blackmore, Research Programmes Manager at Alzheimer’s Research UK, notes that oestrogen-only therapy is currently prescribed primarily to women who have undergone a hysterectomy due to endometrial cancer risks. Previous research also indicates that combination therapies involving progestin might increase dementia risk. Blackmore stresses that the new study is not a reason for women to start or stop hormone treatments to ward off dementia, calling instead for larger, more diverse clinical trials.
Frequently Asked Questions
Does oestrogen therapy prevent Alzheimer’s disease?
No. The observational study establishes an association between oestrogen-only hormone therapy and a lower risk of dementia signs, but it does not prove that the hormone treatment actively prevents or treats the condition.
Why is oestrogen-only therapy restricted primarily to women with hysterectomies?
According to clinical standards cited by researchers, oestrogen-only therapy carries an increased risk of endometrial cancer when a uterus is present, meaning it is typically prescribed only after a hysterectomy.
Can all types of hormone replacement therapy lower dementia risk?
No. Past research indicates that combination therapies using both oestrogen and progestin may actually increase the risk of dementia, making the specific type of hormone therapy a critical variable.
Explore more articles on brain health, medical research, and neurology updates by subscribing to our newsletter today.
Keep reading